Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The DEA has the authority to reclassify drugs in consultation with the Department of Health and Human Services (HHS).”
UnverifiableConfidence: LOW

Reasoning

The excerpt from the Reason.com article cites the Controlled Substances Act and notes that the DEA, when reclassifying drugs, does so in consultation with the Department of Health and Human Services. This directly confirms the claim.

On confidence: The provided source explicitly states that the DEA has the authority to reclassify drugs in consultation with HHS.

Important context

The authority is derived from the Controlled Substances Act, which assigns the DEA the role of scheduling drugs, with HHS providing medical and scientific input during reclassification decisions.

Evidence

Supporting (1)

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…

Limitations

The evidence is limited to a single secondary source summarizing the statutory framework; no primary legal text is provided, but the source reliably reflects the established process. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 1, 2026, 4:49 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum